International Journal of Cardiology
Volume 152, Issue 2 , Pages 202-206 , 20 October 2011

Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein IIb/IIIa complex—in vitro and in vivo study

  • Kohsuke Hagisawa

      Affiliations

    • Department of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan
    • ,
  • Toshihiko Nishioka

      Affiliations

    • Division of Cardiology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 49 228 3587; fax: +81 49 226 5274.
    • ,
  • Ryo Suzuki

      Affiliations

    • Department of Biopharmaceutics, School of Pharmaceutical Science, Teikyo University, 1091-1 Suwarashi, Sagamiko, Sagamihara, Kanagawa 229-0195, Japan
    • ,
  • Tomoko Takizawa

      Affiliations

    • Department of Biopharmaceutics, School of Pharmaceutical Science, Teikyo University, 1091-1 Suwarashi, Sagamiko, Sagamihara, Kanagawa 229-0195, Japan
    • ,
  • Kazuo Maruyama

      Affiliations

    • Department of Biopharmaceutics, School of Pharmaceutical Science, Teikyo University, 1091-1 Suwarashi, Sagamiko, Sagamihara, Kanagawa 229-0195, Japan
    • ,
  • Bonpei Takase

      Affiliations

    • Division of Biomedical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan
    • ,
  • Masayuki Ishihara

      Affiliations

    • Division of Biomedical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan
    • ,
  • Akira Kurita

      Affiliations

    • Division of Biomedical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan
    • ,
  • Nobuo Yoshimoto

      Affiliations

    • Division of Cardiology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
    • ,
  • Fumitaka Ohsuzu

      Affiliations

    • First Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan
    • ,
  • Makoto Kikuchi

      Affiliations

    • Department of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan

Received 12 February 2010 ,Revised 19 June 2010 ,Accepted 4 July 2010.

References 

  1. Masses, tumors, and source of embolus. In:  Feigenbaum H,  Armstrong WF,  Ryan T editor. Feigenbaum's echocardiography. 6th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 701–734
  2. Rose SC, Zwiebel WJ, Murdock LE, et al. Insensitivity of color Doppler flow imaging for detection of acute calf deep venous thrombosis in asymptomatic postoperative patients. J Vasc Interv Radiol. 1993;4:111–117
  3. Popma JJ. Coronary arteriography and intravascular imaging. In:  Libby P,  Bonow RO,  Mann DL,  Zipes DP editor. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed.. Philadelphia, PA: Saunders Elsevier; 2008;p. 495–496
  4. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;94:3334–3340
  5. Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol. 1998;81:58G–61G
  6. Wu Y, Unger EC, McCreery TP, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol. 1998;33:880–885
  7. Takeuchi M, Ogunyankin K, Pandian NG, et al. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr. 1999;12:1015–1021
  8. Demos SM, Alkan-Onyuksel H, Kane BJ, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol. 1999;33:867–875
  9. Hamilton A, Huang SL, Warnick D, et al. Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation. 2002;105:2772–2778
  10. Alonso A, Della Martina A, Stroick M, et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke. 2007;38:1508–1514
  11. Suzuki R, Takizawa T, Negishi Y, et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release. 2007;117:130–136
  12. Suzuki R, Takizawa T, Negishi Y, et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release. 2008;125:137–144
  13. Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Maruyama K. Effective gene delivery with liposomal bubbles and ultrasound as novel non-viral system. J Drug Target. 2007;15:531–537
  14. Gyongyossy-Issa MIC, Muller W, Devine DV. The covalent coupling of Arg-Gly-Asp-containing peptides to liposomes: purification and biochemical function of the lipopeptide. Arch Biochem Biophys. 1998;353:101–108
  15. Nishiya T, Sloan S. Interaction of RGD liposomes with platelets. Biochem Biophys Res Commun. 1996;224:242–245
  16. Szoka F, Papahadjopolus D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Sci U S A. 1978;75:4194–4198
  17. Beer JH, Springer KT, Coller BS. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood. 1992;79:117–128
  18. NIH image home page. http://rsb.info.nih.gov/nih-image/ Accessed January 29, 2010.
  19. Glauert AM, Lewis PR. Biological specimen preparation for transmission electron microscopy. In:  Glauert AM editors. Practical methods in electron microscopy Volume 17. London, UK: Portland Press; 1998;
  20. Steffen W, Fishbein MC, Luo H, et al. High intensity, low frequency catheter-delivered ultrasound dissolution of occlusive coronary artery thrombi: an in vitro and in vivo study. J Am Coll Cardiol. 1994;24:1571–1579
  21. Nishioka T, Luo H, Fishbein MC, et al. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study. J Am Coll Cardiol. 1997;30:561–568
  22. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nature Rev Drug Discov. 2004;3:527–532
  23. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol. 2003;28:625–653
  24. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990;268:235–237
  25. Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A, Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta. 1992;1128:44–49
  26. Lee TY, Lin CT, Kuo SY, Chang DK, Wu HC. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery. Cancer Res. 2007;67:10958–10965
  27. Chang DK, Lin CT, Wu CH, Wu HC. A novel peptide enhances therapeutic efficacy of liposomal anticancer drugs in mice models of human lung cancer. PLoS ONE. 2009;4:e4171
  28. Storm G, Oussoren C, Peelers PAM, Barenholz Y. Tolerability of liposomes in vivo. In:  Gregoriadis G editors. Liposome technology. Boca Raton, FL: CRC Press, Inc.; 1993;p. 345–383
  29. Davidson RN, Croft SL, Scott A, Maini M, Moody AH, Bryceson AD. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet. 1991;337:1061–1062
  30. Guaglianone P, Chan K, DelaFlor-Weiss E, et al. Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). Invest New Drugs. 1994;12:103–110
  31. Gabizon A, Peretz T, Sulkes A, et al. Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol. 1989;25:1795–1803
  32. Carpenter CP, Woodside MD, Kinkead ER, King JM, Sullivan LJ. Response of dogs to repeated intravenous injection of polyethylene glycol 4000 with notes on excretion and sensitization. Toxicol Appl Pharmacol. 1971;18:35–40
  33. Wei K, Mulvagh SL, Carson L, et al. The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78, 383 administered contrast doses. J Am Soc Echocardiogr. 2008;11:1202–1206
  34. Hutter JC, Luu HM, Mehlhaff PM, Killam AL, Dittrich HC. Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent. J Ultrasound Med. 1999;18:1–11
  35. Meyer A, Auernheimer J, Modlinger A, Kessler H. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting. Curr Pharm Des. 2006;12:2723–2747
  36. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(10)00543-7

doi: 10.1016/j.ijcard.2010.07.016

International Journal of Cardiology
Volume 152, Issue 2 , Pages 202-206 , 20 October 2011

Article Tools

* Image Usage & Resolution